EQT to Acquire Coller Capital for $3.2B

EQT agreed to acquire secondaries firm Coller Capital for $3.2bn. The deal discussion includes commentary from Carlyle’s Robert Schmidt about an improving IPO window following Medline’s listing.

The transaction is framed as part of the broader liquidity and exit-channel conversation for private markets, with secondaries activity positioned as a bridge when public-market access improves.